Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A8550 Telatinib (BAY 57-9352)Target: VEGFR|PDGFR|c-KitSummary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor -
A8555 Vandetanib (ZD6474)Target: VEGFR|EGFRSummary: VEGFR2/EGFR antagonist -
A8557 TAE226 (NVP-TAE226)1 CitationTarget: FAKSummary: FAK inhibitor,potent and ATP-competitive -
A8603 GNF 2Summary: Bcr-Abl inhibitor -
A8604 GNF 5Target: Bcr-AblSummary: Bcr-Abl inhibitor -
A8605 1-Naphthyl PP1Summary: Src family kinases inhibitor -
A8606 PD 180970Summary: P210bcr/abl tyrosine kinase inhibitor -
A8607 PPY ATarget: Abl kinasesSummary: Abl kinases inhibitor -
A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R inhibitor -
A8661 MNSSummary: Inhibitor of Src/Syk tyrosine kinases

